Publications
758
Citations
25,445
Est. group size
~1
Recurring co-author estimate
Active years
55
Publishing since 1972
This publication record appears to combine at least two distinct research areas, likely reflecting more than one person sharing this name: one line of work focuses on food allergy, including oral immunotherapy for peanut, cashew, and sesame allergies, allergy management in schools, and treatments like omalizumab; another line covers cancer treatment (biliary tract cancer drug trials), nanoparticle-based drug delivery, and stem cell or immune cell therapies for conditions like arthritis and glioblastoma. The food allergy work centers on improving diagnosis, treatment, and quality of life for patients with severe allergies, while the other work explores experimental therapies using nanotechnology and immune cells for various diseases.
Publication output has fluctuated over the past decade, peaking in 2020 (68 papers) and generally declining since, with the most recent 5-year average (27.8/year) lower than earlier years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- CCR2 Orchestrates Preferential Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Rheumatoid Arthritis
MedComm · 2026
- Quality of life is impaired in shrimp allergic adults and caregivers
UNC Libraries · 2026
- Enhancing nasal retention: using the mucosal blanket to structure sprays
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
Journal of Hepatology · 2025
- Peanut Oral Immunotherapy in Children with High-Threshold Peanut Allergy
NEJM Evidence · 2025
- Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo
ACS Nano · 2025
- Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies
Journal of Allergy and Clinical Immunology · 2025
- CD47 Knock‐Out Using CRISPR‐Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo
Advanced Science · 2025
- Development of a validated, updated North American pediatric food allergy anaphylaxis management plan
Annals of Allergy Asthma & Immunology · 2025
- Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT
Journal of Allergy and Clinical Immunology · 2025
- Safety and efficacy of cashew oral immunotherapy in children under age 3
The Journal of Allergy and Clinical Immunology In Practice · 2025
- Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer
The Oncologist · 2025
- Infusion of Induced Regulatory T Cells Alleviates Atherosclerosis by Reducing Pathological Macrophage‐Like Vascular Smooth Muscle Cells
MedComm · 2025
- Micheliolide interferes PKM2-P65 interaction and inhibits inflammasome activation in macrophage after ischemic stroke
International Immunopharmacology · 2025
- Management of Food Allergy in Schools: Clinical Report
PEDIATRICS · 2025
- Journal of Allergy and Clinical Immunology×63
- The Journal of Allergy and Clinical Immunology In Practice×56
- PEDIATRICS×32
- Annals of Allergy Asthma & Immunology×17
- Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature×12
- Girish Vitalpur
Medicine · Indiana University
- Rebecca Scherzer
Medicine · The Ohio State University
- David R. Stukus
Medicine · The Ohio State University
- Bryan Martin
Medicine · The Ohio State University
- Irene Mikhail
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile